Markets are complex adaptive systems—forever imperfect yet broadly efficient. Alpha emerges at the bleeding edge where human insight meets rigorous data. Our philosophy unites deep fundamental research with quantitative discipline so we can exploit inefficiencies without abandoning prudence.
Breakthroughs in machine learning are slashing drug‑discovery timelines and boosting diagnostic accuracy. We allocate to companies that harness deep neural networks for molecule screening, image analysis, and predictive biomarkers.
We view environmental and social factors as material risk vectors, not marketing optics. Engagement, not divestment, is our first lever when issues arise.
Digital assets are the plumbing of tomorrow’s financial system. We express views via liquid majors for macro hedging and via selective venture rounds in tokenization or Web3 infrastructure, guided by on‑chain analytics and strict custody protocols.
